Literature DB >> 1338558

Pharmacological profiles of the GABA and acetylcholine receptors from the nematode, Ascaris suum.

R J Walker1, L Colquhoun, L Holden-Dye.   

Abstract

The pharmacological profiles of the acetylcholine and GABA receptors of Ascaris muscle have been investigated. Acetylcholine excites the muscle through activation of a nicotinic receptor which resembles the mammalian ganglionic receptor. DMPP is a potent agonist and alpha-bungarotoxin is a weak antagonist. GABA inhibits the muscle through activation of a chloride-linked receptor which in terms of agonist profile resembles the mammalian GABA-A receptor. However, bicuculline is inactive and picrotoxin is a very weak antagonist. Avermectin acts as a non-competitive antagonist at this GABA receptor with an IC-50 value in the low microM range.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338558

Source DB:  PubMed          Journal:  Acta Biol Hung        ISSN: 0236-5383


  4 in total

Review 1.  Nematode cys-loop GABA receptors: biological function, pharmacology and sites of action for anthelmintics.

Authors:  Michael V Accardi; Robin N Beech; Sean G Forrester
Journal:  Invert Neurosci       Date:  2012-03-20

2.  Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells.

Authors:  N Le Novère; J P Changeux
Journal:  J Mol Evol       Date:  1995-02       Impact factor: 2.395

3.  Pharmacological characterization of the homomeric and heteromeric UNC-49 GABA receptors in C. elegans.

Authors:  Bruce A Bamber; Roy E Twyman; Erik M Jorgensen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Nematicidal activity of silver nanoparticles from the fungus Duddingtonia flagrans.

Authors:  Anna Claudia Mombrini Silva Barbosa; Laryssa Pinheiro Costa Silva; Carolina Magri Ferraz; Fernando Luiz Tobias; Jackson Victor de Araújo; Barbara Loureiro; Gracilene Maria Almeida Muniz Braga; Francielle Bosi Rodrigues Veloso; Filippe Elias de Freitas Soares; Marcio Fronza; Fabio Ribeiro Braga
Journal:  Int J Nanomedicine       Date:  2019-04-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.